#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Adrenoleukodystrophy Blastic plasmacytoid dendritic cell neoplasia Oesophageal squamous cell carcinoma stage II Alagille syndrome Neuroendocrine carcinoma ABO haemolytic disease of newborn Scedosporium infection Cystic fibrosis gastrointestinal disease Acute myeloid leukaemia Anti-myelin-associated glycoprotein antibodies positive Plasma cell myeloma recurrent Chronic lymphocytic leukaemia recurrent Mucous membrane pemphigoid Primary hyperoxaluria Univentricular heart More trials…

    Learn about Rare Diseases

    Ornithine transcarbamoylase deficiency Ocular melanoma – Basic Information Angiosarcoma metastatic – Trials in Disease Burkitt’s lymphoma Familial amyotrophic lateral sclerosis – Basic Information Gaucher’s disease type III – Basic Information Retinitis pigmentosa – Diagnostics Congenital generalised lipodystrophy Biotinidase deficiency – Life with Disease Lysosomal storage disorder – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Upacicalcet Sodium Hydrate Medi0618 BI-1607 IPN01195 ALN-961583 BW-20805 Pasireotide VERT-002 Macitentan Sodium Phosphate APROTININ ISPAGHULA HUSK Charcoal, Activated Epoetin Alfa Flutamide Vortioxetine Vilobelimab Human Serum Albumin 5% Sodium Chloride Ph. Eur. Natalizumab More therapies…

    Learn about Your Condition

    Rhabdoid tumour of the kidney Coronary artery disease Knee arthroplasty Lichen sclerosus Sarcoma metastatic Vulvovaginal pain Acute coronary syndrome Ulcerative keratitis Colorectal cancer stage IV Perinatal depression Drug use disorder Thrombectomy Malignant glioma Conjunctivitis Binge eating More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study on Cannabidiol for Joint Pain in Early Breast Cancer Patients on Hormone Therapy

    Not yet recruiting

    3 1
    Investigated Diseases:
    • Hormone receptor positive breast cancer
    • Breast cancer
    Investigated Drugs:
    • Cannabidiol
    France

  • Study on JDQ443 and Docetaxel for Patients with Advanced KRAS G12C Mutant Non-Small Cell Lung Cancer

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer
    Investigated Drugs:
    • 1-{6-[(4M)-4-(5-Chloro-6-Methyl-1H -Indazol-4-Yl)-5-Methyl-3-(1-Methyl-1H -Indazol-5-Yl)-1H -Pyrazol-1-Yl]-2-Azaspiro[3.3]Heptan-2-Yl}Prop-2-En-1-One
    • Docetaxel
    Finland Greece Hungary Iceland Italy Portugal +3

  • Study on the Effects of Adalimumab, Vedolizumab, and Tofacitinib on Heart Health in Patients with Ulcerative Colitis

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Colitis ulcerative
    Investigated Drugs:
    • Vedolizumab
    • Golimumab
    • Tofacitinib
    France

  • Study of Oxytocin Nasal Spray as Add-on Treatment for Children with Autism Spectrum Disorder and Intellectual Disability: Safety and Feasibility Assessment

    Not yet recruiting

    4 1 1
    Investigated Drugs:
    • Oxytocin
    • Sodium Chloride
    France

  • Study on the Safety of Sirolimus for Children with Familial Adenomatous Polyposis

    Not yet recruiting

    2 1 1 1
    Investigated Drugs:
    • Sirolimus
    France

  • Study on the Safety and Effectiveness of Delandistrogene Moxeparvovec for Patients with Duchenne Muscular Dystrophy

    Not yet recruiting

    3 1
    Investigated Diseases:
    • Duchenne muscular dystrophy
    Investigated Drugs:
    • Delandistrogene Moxeparvovec
    Belgium France Germany Italy Spain Sweden
Previous Page
1 … 838 839 840 841 842 … 1,657
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!